Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia

NCT05237960 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Erythroplakia
Oral Leukoplakia

Interventions

PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
DRUG: Extended Release Metformin Hydrochloride
DRUG: Placebo Administration

Sponsor

University of Arizona

Collaborators

[object Object]